Yondo

Estonia → Baltics → PL/Nordics
Outcomes-first

Hybrid therapy that scales: online & in-person, built for outcomes

Launching in Estonia, expanding across the Baltics and nearby markets (Poland, Nordics). A verified therapist network, smart matching, and enterprise coverage (B2B) create a durable wedge with measurable results.

2028 Revenue (run-rate)

€2,956,000

incl. take-rate + subs

B2B logos by 2028

50

employers under contract

Active therapists 2028

120

verified supply

EBITDA 2028

€2,316,000

78% margin

Go-to-market & expansion

  • Beachhead: Estonia with dense verified supply and B2B pilots.
  • Baltics scale: Latvia/Lithuania leveraging cross-border therapist network.
  • Nearby growth: Poland and Nordics via employer channels and partnerships.

Business model

  • Marketplace take-rate on sessions (24% blended).
  • B2B subscriptions (access, analytics, rollout support).
  • Therapist Pro subscriptions (tools, priority, data insights).

GMV

Therapy spend flowing through the platform.

EBITDA

Break-even in 2027; strong operating leverage by 2028.

Revenue (annual)

+ profitability from 2027; capital efficient growth.

Financial plan (2026–2028)

All numbers in euros (€); sessions include both online and in-person.

Metric202620272028
Active therapists4075120
B2C users2,0006,00015,000
B2B clients (companies)102550
Active employees in B2B6002,5006,000
Sessions / year (total)12,00045,000130,000
Avg price per session€75€78€80
GMV€900,000€3,510,000€10,400,000
Payouts to therapists–€684,000–€2,667,000–€7,904,000
Platform fee€216,000€843,000€2,496,000
B2B subscriptions€40,000€160,000€360,000
Therapist Pro subscriptions€15,000€40,000€100,000
Total revenue€271,000€1,043,000€2,956,000
Marketing & growth–€90,000–€140,000–€220,000
Team & operations–€210,000–€260,000–€320,000
Tech infrastructure–€40,000–€50,000–€65,000
G&A, licenses, legal–€20,000–€25,000–€35,000
Total operating expenses–€360,000–€475,000–€640,000
EBITDA–€89,000€568,000€2,316,000
Margin on revenue-33%54%78%
Net income (after tax)–€100,000€460,000€1,850,000

Why now

  • Employer budgets shifting to measurable wellbeing impact.
  • Hybrid care preferred: online convenience + in-person depth.
  • Regulatory and cultural tailwinds in EU markets.

Moat

  • Verified supply + outcomes & retention data.
  • Matching that optimizes for fit and recurrence.
  • Employer integrations & procurement readiness.

Key risks

  • Therapist liquidity when entering new regions.
  • Price sensitivity vs. quality and verification costs.
  • Enterprise sales cycles and localization.

Interested in partnering or investing?

Request our deck and data room. We’ll follow up quickly.